
LIOM is developing a disruptive, high-throughput, wearable Raman spectroscopy platform for non-invasive molecular sensing, starting with glucose.
This talk will introduce LIOM’s stepwise approach to translating Raman spectroscopy from benchtop in-vitro measurements towards a prospective, independent in-vivo clinical study. That study demonstrated a 14.5% error (similar to first-generation invasive CGMs) without subject calibration based on measurements with a benchtop system. We then discuss LIOM’s novel miniaturized high-throughput photonics system where initial tests meet our requirements despite a dramatic decrease in size.

Adler Perotte, MD, MA is Chief Science and Innovation Officer at LIOM, where he leads scientific strategy along with a team of experts to develop a wearable Raman spectroscopy platform for non-invasive molecular sensing, starting with glucose. He received his MD and MA in Biomedical Informatics from Columbia University and served as a faculty member at Columbia University where his lab studied machine learning applications in healthcare and photonics for non-invasive sensing. At LIOM, he guides the research of machine learning as well as miniaturized photonics systems designed to preserve Raman’s molecular specificity while meeting the constraints of LIOM’s product including wearable form factor, optical throughput, low power, robustness, and manufacturability.

| 